Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine
Adverse events following immunizations (AEFIs) with recombinant zoster vaccine (RZV) are underexplored in fragile populations. This study aims to assess incidence, duration, and characteristics of AEFIs, focusing on the impact of sex, age, and prior Herpes Zoster (HZ) infection in a frail population...
Saved in:
| Main Authors: | Maria Costantino, Valentina Giudice, Giuseppina Moccia, Monica Ragozzino, Salvatore Calabrese, Francesco Caiazzo, Massimo Beatrice, Walter Longanella, Simona Caruccio, Candida Iacuzzo, Carmen Giugliano, Mariagrazia Bathilde Marongiu, Giovanni Genovese, Bianca Serio, Emilia Anna Vozzella, Amelia Filippelli, Francesco De Caro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pathogens |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/14/2/195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Awareness and acceptability of herpes zoster vaccination in people living with HIV
by: Christian Motet, et al.
Published: (2025-08-01) -
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy
by: Angioletta Lasagna, et al.
Published: (2023-12-01) -
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
by: Agnes Mwakingwe-Omari, et al.
Published: (2023-12-01) -
An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy
by: Francesco De Caro, et al.
Published: (2025-02-01) -
A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age
by: Xinghuo Pang, et al.
Published: (2024-12-01)